Lipid-based Polyene Antifungal [EPC]

9839 reported adverse events

Drugs of this class: AMPHOTERICIN B AMPHOTERICIN B, DIMYRISTOYLPHOSPHATIDYLCHOLINE, DL- AND DIMYRISTOYLPHOSPHATIDYLGLYCEROL, DL-

These side effects are most commonly reported by patients taking drugs of the Lipid-based Polyene Antifungal [EPC] class:

#	Side effect	Count
0	DRUG INEFFECTIVE	1569
1	OFF LABEL USE	706
2	PYREXIA	616
3	SEPSIS	419
4	HYPOKALAEMIA	403
5	FEBRILE NEUTROPENIA	394
6	PNEUMONIA	387
7	RENAL FAILURE	356
8	CONDITION AGGRAVATED	332
9	RENAL IMPAIRMENT	332

See all common reactions for Lipid-based Polyene Antifungal [EPC]

Drugs of the Lipid-based Polyene Antifungal [EPC] class are most commonly taken among patients reporting these side effects:

#	Side effect	Count	Frequency
0	SPLENIC CANDIDIASIS	7	0.3333
1	CAROTID ARTERY INSUFFICIENCY	6	0.2400
2	PYELONEPHRITIS FUNGAL	7	0.2188
3	RHINOCEREBRAL MUCORMYCOSIS	8	0.2162
4	OSTEOMYELITIS FUNGAL	14	0.1750
5	HEPATOSPLENIC CANDIDIASIS	17	0.1700
6	CHOROIDITIS	35	0.1613
7	GEOTRICHUM INFECTION	21	0.1500
8	PNEUMONIA MORAXELLA	7	0.1489
9	CENTRAL NERVOUS SYSTEM FUNGAL INFECTION	13	0.1477

See all enriched reactions for Lipid-based Polyene Antifungal [EPC]